Generic drugmaker Dr Reddy's Labs reported 7% growth in its net profit at Rs 1,347 crore in the September quarter, compared with Rs 1,255 crore in the same quarter of last year. Revenue from ...

Dr. Reddy's Laboratories Limited RDY reported second-quarter fiscal 2026 earnings of 19 cents per American Depositary Share (ADS), which beat the Zacks Consensus Estimate of 18 cents. The company ...

Media Release Entered into strategic collaboration with Dr. Reddy’s for commercialisation of eftilagimod alfa (efti) in all countries outside North America, Europe, Japan, and Greater ChinaIn January ...

Dr Reddy's Q2 Results FY2026: Dr Reddy's Laboratories reported its Q2FY26 results, posting a revenue of Rs 8,805 crore, up 9.8 per cent from Rs 8,016 crore in Q2FY25. The company's EBITDA stood at Rs ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy’s Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR 14.37 billion or ...

Mumbai: Dr. Reddy’s Laboratories reported a 14.4 percent year-on-year decline in consolidated net profit to Rs 1,210 crore in ...